The Stork Ib2C, Inc., A Rinovum Women’s Health Company, Bridging the Gap for Women With Limited Access to Fertility Services and Local Clinics

The Stork® OTC offers solution to findings
revealed in a recent study showing reproductive-age women need better
access to at-home fertility treatment options

PITTSBURGH–(BUSINESS WIRE)–While fertility clinics may be difficult for some women to access, there
are other more accessible options. Pittsburgh-based medical device
company, Rinovum Women’s Health, offers solutions for building families
naturally with an at-home conception device designed to help with
becoming pregnant. This innovative alternative can be especially helpful
for the nearly 40 percent of reproductive-age women in the United States
with limited or no local access to assisted reproductive technology
clinics.

The Stork® OTC (www.storkotc.com)
is an FDA-cleared over-the-counter treatment device designed to optimize
the chances of at-home conception using the cervical cap insemination
technique. It is a safe, easy-to-use, accessible treatment option to
help women become pregnant during ovulation without a prescription and
in the privacy of their own home.

According to a recent study published in the journal Fertility
& Sterility
, 25 million reproductive-age women in the United
States have limited or no access to assisted reproductive technology
(ART) clinics, which provide services that are vital to many women
trying to become pregnant.

The study used data from the Centers for Disease Control and Prevention
to pinpoint infertility clinics in proximity to where women live in
order to evaluate and assess viable access to infertility care in the
United States.

“The Stork OTC is a uniquely designed medical device that has helped
many couples come closer to their goal of building a family. It’s an
easy-to-use, drug-free, cost-effective way to take control and optimize
your chances to conceive without driving to distant clinics,” explained
Dr. Michael J. Pelekanos, Board Certified OB/GYN based in Monroeville,
Pa.

This type of treatment has been used effectively in the professional
setting, but now it’s readily available to couples at home.

The Stork OTC can be used for common fertility issues in both men and
women including:

  • Couples with unexplained infertility
  • Men with low sperm count or low sperm motility
  • Women with unfavorable vaginal environment (pH imbalances)
  • Couples trying to become pregnant without having intercourse

The Stork OTC is available for purchase at select retailers nationwide
and online for the average retail price of $79.99, making it more
accessible and less expensive than other first-line options for all
couples trying to conceive. To learn more about how The Stork OTC works,
watch the full video here.
For more information and retailer and online availability, as well as
pregnancy stories, visit www.storkotc.com.

About The Stork Ib2C, Inc., A Rinovum Women’s Health Company

Rinovum Women’s Health is a privately held women’s health company
dedicated to bringing products into the market that will enhance women’s
lives and empower them to take charge of their health. The Stork Ib2C,
Inc., A Rinovum Women’s Health Company, launched its flagship product,
The Stork® OTC, which is a conception device for reproductive health to
assist in natural fertility and conception in the privacy of the
patient’s home. Rinovum Women’s Health aims to support the development
of products that are easy-to-use and safe, as well as a more economical
way for a couple to address some of these issues. For more information
about Rinovum Women’s Health, The Stork Ib2C, Inc., and The Stork OTC,
visit www.rinovum.com
and www.storkotc.com.

Contacts

The Stork Ib2C, Inc., A Rinovum Women’s Health Company
Brianna
Clements, 724-241-8936
bfreeman@rinovum.com